Commentary on “Health-related quality-of-life, complications, and mortality rates after geriatric acetabular fracture”

Dear Editor, We read with considerable interest the systematic review and meta-analysis by Khalifa et al comparing health-related quality of life, functional outcomes, complications, and mortality after operative versus non-operative management of geriatric acetabular fractures (GAF)[1,2]. By synthesizing data from 5680 patients and following PRISMA and AMSTAR recommendations, the authors provide timely evidence on a difficult and increasingly frequent clinical scenario in an aging population. We congratulate the authors on drawing attention to the scarcity of robust health-related quality of life (HRQoL) and functional data and on quantifying the balance between the higher rates of complications and conversion to total hip arthroplasty (THA) after operative management (OM) and the lower 1-year mortality associated with surgery[1]. The use of random-effects models and GRADE assessment enhances the transparency of the reported effect estimates and the confidence that can be placed in them. However, the interpretation of the apparent survival advantage with OM warrants careful consideration. Khalifa et al report an odds ratio of 0.42 for 1-year mortality in favor of OM, while also noting that patients managed non-operatively (NOM) were significantly older in most contributing studies[1]. In many primary cohorts, comorbidity burden, frailty, pre-injury mobility, cognitive function, and treatment goals were incompletely described or heterogeneously reported[3–5]. Under these circumstances, substantial confounding by indication seems likely, with fitter patients preferentially selected for surgery and the frailest individuals more often triaged to NOM or palliative pathways. We therefore suggest that the magnitude of the mortality benefit should be interpreted with caution, especially when extrapolating these results to very frail or multimorbid patients, who appear to be under-represented in the operative cohorts[4,5]. In addition, the binary comparison of “OM versus NOM” may conceal important heterogeneity within both treatment groups. In the OM arm, the review combines open reduction and internal fixation, percutaneous fixation, and acute total hip arthroplasty, which differ in operative trauma, rehabilitation trajectories, and the risk of early and late complications[1,6,7]. Likewise, NOM encompasses strategies ranging from prolonged bed rest and traction to pathways prioritizing early mobilization and multidisciplinary geriatric co-management[3,8]. For day-to-day decision-making, surgeons and geriatricians frequently need to know which specific operative approach, if any, offers a net advantage over optimized conservative care for a given frailty and functional profile, rather than whether “surgery” as a whole is superior to “no surgery.” Future research might therefore prioritize more granular, risk-adjusted comparisons that integrate comprehensive geriatric assessment with standardized descriptions of both operative and non-operative care pathways. Propensity score methods, inverse probability weighting, or well-designed prospective registries could partially address confounding by indication, while cause-specific and competing-risk analyses may help disentangle deaths related to fracture management from those driven by underlying comorbidities[3–5,7]. In parallel, incorporating age-appropriate HRQoL instruments and documenting outcomes such as institutionalization, return to independent living, and subsequent falls would provide a more patient-centered understanding of the long-term consequences of the initial treatment decision[9]. In summary, Khalifa et al have produced a valuable synthesis that advances our understanding of outcomes after GAF and highlights the need for higher-quality data. We believe that more nuanced, frailty-informed comparisons between specific operative strategies and contemporary non-operative protocols will further clarify which patients are most likely to gain both survival and quality-of-life benefits from surgery. We look forward to future studies building on this important work.